Semax 5mg

$19.00

Category

Description

SEMAX 5mg


Product Overview

SEMAX is a synthetic peptide widely referenced in scientific literature for its neuroprotective and neurogenic (neuro-restorative) properties. It is derived from a fragment of adrenocorticotropic hormone (ACTH 4–7) and was originally developed by the Institute of Molecular Genetics at the Russian Academy of Sciences.

Unlike the parent ACTH molecule, SEMAX is non-hormonal, making it particularly relevant for neurological and cognitive research without endocrine system activation. Its modified structure enhances peptide stability while retaining biological signalling relevance within the central nervous system.


Research Background

SEMAX has been studied primarily in neuroscience and neurobiology research models. Scientific literature suggests that SEMAX may influence signalling pathways associated with neuronal survival, synaptic plasticity, and adaptive stress responses.

Research has also explored SEMAX’s interaction with neurotrophic factors such as brain-derived neurotrophic factor (BDNF), as well as its potential role in modulating inflammatory and oxidative stress responses within neural tissue.


Areas of Research Interest

Current laboratory research involving SEMAX includes investigation into:

  • Neuroprotection and neuronal survival mechanisms

  • Neuroplasticity and synaptic signalling

  • Cognitive and memory-related research models

  • Stress-response and adaptive neural pathways

  • Neurorestorative and recovery-focused studies

These research areas remain experimental and are explored strictly within controlled laboratory environments.


Conclusion

SEMAX represents a well-documented peptide within neurological research, offering a non-hormonal platform for investigating neuroprotective and neuroplastic mechanisms. Its origin from ACTH fragments, combined with enhanced stability and CNS relevance, continues to make SEMAX a subject of interest in academic and laboratory-based research.


Technical Details

  • Synonyms: Semax, ACTH (4–7), Pro-Gly-Pro-, MEHFPGP, I5FAL2585H
  • Sequence: MEHFPGP
  • IUPAC Condensed: H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
  • Molecular Weight: 813.9 g/mol
  • CAS Number: 80714-61-0
  • PubChem CID: 9811102

Reviews

There are no reviews yet

Only logged in customers who have purchased this product may leave a review.

Related Products

Cartalax 20mg
Bundle ‘Wolverine Stack
BPC-157 5mg
Adipotide (FTPP) – 5mg Adipotide (FTPP), also known as prohibitin-targeting peptide 1, is a synthetic peptidomimetic supplied as a lyophilised powder for research use only. It is designed with a bifunctional structure: a targeting sequence that binds to prohibitin/ANXA2 proteins on blood vessels, and a pro-apoptotic domain (_D(KLAKLAK)_2) that disrupts mitochondrial function. This selective action makes Adipotide a research tool of interest in studies of adipose tissue biology, metabolic regulation, and vascular targeting strategies. Research Focus and Areas of Interest 1. Targeted Fat Tissue Reduction Researchers are investigating Adipotide’s ability to bind endothelial cells in white adipose tissue and induce apoptosis. This targeted mechanism allows study of fat mass reduction via vascular disruption, without direct effects on muscle or organ tissues. 2. Metabolic Regulation Pathways By altering adipose tissue mass, Adipotide may influence glucose handling and insulin response. Research has shown interest in how vascular targeting peptides might intersect with pathways linked to type 2 diabetes and systemic metabolism. 3. Vascular Targeting in Oncology Because prohibitin and related proteins can also appear in tumour blood vessels, Adipotide is being studied as a model for selective angiogenic disruption. This opens a potential pathway for research into cancer vascular biology. 4. Tissue Remodeling and Signaling Laboratory studies often explore Adipotide (FTPP) for its role in tissue remodeling, focusing on signaling pathways that regulate cellular communication and local microenvironments. Conclusion Adipotide (FTPP) represents a unique approach to studying fat tissue biology and targeted vascular disruption. Its design allows exploration of obesity, metabolic health, and oncology pathways in controlled laboratory settings. Supplied strictly for research use only, it is not intended for human or veterinary use. Technical Information: • Synonyms: Adipotide; FTPP; Prohibitin-TP01 •Modified Single-Letter Sequence: CKGGRAKDC-GG-D(KLAKLAK)₂ • IUPAC Condensed Amino Acid Sequence: Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-D-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Leu-Ala-Lys • CAS Number: 859216-15-2 • PubChem CID: 163360068 • Further references: PubChem Link Stability, Source, and Handling Stability: Stable for up to 36 months when stored at –20 °C or below, away from light and moisture. Source: Produced via solid-phase peptide synthesis; supplied with Certificate of Analysis (COA) confirming purity and identity. Reconstitution: Reconstitute with Bacteriostatic Water. After reconstitution, aliquot and store at –80 °C to prevent degradation. Usage: Product is prepared for LABORATORY RESEARCH ONLY. Adipotide for sale at Pure Peptides UK is limited to scientific research and education only – Only buy Adipotide if you are a licenced researcher.